Since this first report, there has been vast interest in determining the relationship between NLRP3 activation and other inflammatory conditions including type 2 diabetes, atherosclerosis, and steatohepatitis, among others [56–58]. The gene discussed is NLRP3; the disease is type 2 diabetes mellitus.